Does warfarin prevent recurrent ischemic stroke or death compared to aspirin in patients requiring prevention of recurrent ischemic stroke?
Warfarin and aspirin demonstrate comparable efficacy and safety for the prevention of recurrent ischemic stroke over a two-year period.
Over two years, we found no difference between aspirin and warfarin in the prevention of recurrent ischemic stroke or death or in the rate of major hemorrhage. Consequently, we regard both warfarin and aspirin as reasonable therapeutic alternatives.
Mohr et al. (Thu,) studied this question.